Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000725258 | SCV000335385 | uncertain significance | not provided | 2015-09-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000317810 | SCV000714962 | likely benign | not specified | 2017-04-14 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV002317806 | SCV000850871 | likely benign | Inborn genetic diseases | 2017-04-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001078639 | SCV001005694 | likely benign | Cortical dysplasia-focal epilepsy syndrome | 2024-08-29 | criteria provided, single submitter | clinical testing |